Northern Trust’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.22M | Sell |
328,975
-51,945
| -14% | -$193K | ﹤0.01% | 3283 |
|
|
2025
Q1 | $1.23M | Sell |
380,920
-59,745
| -14% | -$193K | ﹤0.01% | 3190 |
|
|
2024
Q4 | $2.45M | Buy |
440,665
+9,982
| +2% | +$55.6K | ﹤0.01% | 2907 |
|
|
2024
Q3 | $4.66M | Buy |
430,683
+63,204
| +17% | +$683K | ﹤0.01% | 2516 |
|
|
2024
Q2 | $7.71M | Sell |
367,479
-6,703
| -2% | -$141K | ﹤0.01% | 2143 |
|
|
2024
Q1 | $11.9M | Buy |
374,182
+8,839
| +2% | +$282K | ﹤0.01% | 1931 |
|
|
2023
Q4 | $7.4M | Buy |
365,343
+1,618
| +0.4% | +$32.8K | ﹤0.01% | 2265 |
|
|
2023
Q3 | $4.63M | Buy |
363,725
+31,358
| +9% | +$399K | ﹤0.01% | 2488 |
|
|
2023
Q2 | $6.01M | Buy |
332,367
+57,938
| +21% | +$1.05M | ﹤0.01% | 2411 |
|
|
2023
Q1 | $4.72M | Sell |
274,429
-392
| -0.1% | -$6.74K | ﹤0.01% | 2503 |
|
|
2022
Q4 | $6.1M | Sell |
274,821
-1,859
| -0.7% | -$41.3K | ﹤0.01% | 2363 |
|
|
2022
Q3 | $2.22M | Buy |
276,680
+2,349
| +0.9% | +$18.9K | ﹤0.01% | 2965 |
|
|
2022
Q2 | $1.92M | Buy |
274,331
+15,051
| +6% | +$105K | ﹤0.01% | 3092 |
|
|
2022
Q1 | $3.92M | Buy |
259,280
+4,908
| +2% | +$74.2K | ﹤0.01% | 2730 |
|
|
2021
Q4 | $5.58M | Buy |
254,372
+64,547
| +34% | +$1.42M | ﹤0.01% | 2620 |
|
|
2021
Q3 | $5.12M | Buy |
189,825
+91,297
| +93% | +$2.46M | ﹤0.01% | 2715 |
|
|
2021
Q2 | $2.37M | Buy |
98,528
+11,385
| +13% | +$274K | ﹤0.01% | 3276 |
|
|
2021
Q1 | $3.78M | Buy |
+87,143
| New | +$3.78M | ﹤0.01% | 2914 |
|